Mirtazapine Tablet, Film Coated
Product Images NDC 70518-2819

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 70518-2819). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Mirtazapine 7.5mg 70518 2819 01)

Mirtazapine is a prescription-only drug manufactured by Rising Pharma Inc. with a source NDC of 57237-0007-30. The medication comes in the form of tablets that are packaged and repackaged by Remedy Repack Inc., with the NDC number 70518-2819-01. The package insert should be followed for guidance on usage directions. The medicine should be stored within a temperature range of 20-26°C and kept away from children. Excursions are allowed to 15-30°C as per USP guidelines. The lot number and expiry date of the medication are not available.*

FDA Label Image

Remedy_label (Remedy Label)

Mirtazapine is a prescription drug that is repackaged by RemedyRepack Inc., Indiana, PA, and manufactured by Rising Pharma, Inc., Allendale, NJ. The drug is regulated and only available with a prescription. It is important to keep the medication out of reach of children. The product's directions for use can be reviewed by reading the package insert. Storage instructions for the drug include keeping it at 20-26°C (63-77°F).*

FDA Label Image

Chemical Structure (Mirtazapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.